Tharimmune (THAR) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

THAR Tharimmune

Watchlist

2.090
+0.020+0.97%

Close Dec 23 16:00 ET

2.080
-0.010-0.48%

Post 16:09 ET

3.11MMarket Cap0.03P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Tharimmune Files to Sell 1.44M Shares of Common Stock for Holders
TipRanksDec 19 16:20 ET
Tharimmune Announces Phase 2 Study Plan for TH104
TipRanksDec 16 09:05 ET
Tharimmune Provides Business Update, Corporate Highlights
TipRanksDec 16 09:05 ET
Express News | Tharimmune: Plan to Report Preliminary Results From Phase 2 Trial in Late 2025
ReutersDec 16 08:05 ET
Express News | Tharimmune: Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis
ReutersDec 16 08:04 ET
Trending Stocks Today | MEDIROM Healthcare Technologies Soars 97.04% Post-Market
Moomoo NewsDec 6 17:20 ET

Comments

Stock_Drift

Yesterday 00:20

$Tharimmune (THAR.US)$

Tharimmune news - Google Search

Trytosaveabit

Dec 16 07:06

Update

$Tharimmune (THAR.US)$ Reuters· just
Tharimmune: Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis

Jaguar8

Dec 16 07:02

NEWS

$Tharimmune (THAR.US)$
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
Monday, 16th December at 8:00 am
BRIDGEWATER, NJ / ACCESSWIRE / December 16, 2024 / Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced plans for initiating a Phase 2 st...

Lambor Tan

Dec 12 10:28

$Tharimmune (THAR.US)$ what

福贵吉祥知足常乐

Dec 8 19:46

$Tharimmune (THAR.US)$ This is interesting, good volumes observed on post market. Keep an eye on this.

Heat List

Overall

No Data